Skip to main content
. Author manuscript; available in PMC: 2012 Nov 22.
Published in final edited form as: J Am Coll Cardiol. 2011 Nov 22;58(22):2301–2309. doi: 10.1016/j.jacc.2011.08.017

Table 1.

Patient characteristics

Characteristic No AKI (N=160) AKI (N=60) P-value**
Age, years 3.3 (0.5, 6.0) 0.6 (0.4, 1.8) < 0.0001
Male, n (%) 84 (53) 26 (43) 0.23
White, n (%) 142 (89) 52 (87) 0.67
Prior surgery, n (%) 76 (48) 24 (40) 0.32
Bypass time, min 92 (67, 127) 113 (84, 172) 0.003
Baseline Scr, mg/dl 0.4 (0.4, 0.6) 0.3 (0.2, 0.4) < 0.0001
Baseline eCCL, ml/min/1.73m2 81.8 (65.0, 99.1) 110.6 (84.0, 144.6) < 0.0001
Baseline urine NGAL, ng/ml 8.5 (4.0, 12.5) 16.0 (10.0, 24.0) < 0.0001
Baseline urine IL-18, pg/ml 1.2 (0.0, 8.1) 0.9 (0.0, 10.0) 0.65
Baseline urine KIM-1, pg/ml 193.9 (83.8, 301.4) 211.5 (96.2, 377.9) 0.43
Baseline urine FABP, ng/ml 7.3 (2.3, 27.4) 10.6 (4.2, 31.2) 0.34
% Scr change 0.0 (0.0, 25.0) 77.5 (64.6, 108.3) < 0.0001
Hospital stay, days 5 (3, 7) 7 (5, 14) < 0.0001
Ventilator, days 1 (1, 2) 2 (1, 2) < 0.0001
Inotrope score 0.0 (0.0, 0.0) 0.0 (0.0, 7.1) 0.19
Death, n (%) 0 (0) 1 (2) 0.27
RACHS score, n (%)
 1 20 (13) 4 (7)
 2 68 (43) 29 (48)
 3 60 (38) 24 (40) 0.14
 4 9 (6) 0 (0)
 5 2 (1) 1 (2)
 6 1 (1) 2 (3)
pRIFLE, n (%)
 R --- 27 (45) ---
 I --- 21 (35)
 F --- 12 (20)
Duration of AKI, days --- 2 (2, 3) ---
Dialysis (%) 0 (0) 0 (0) ---

Median (interquartile range, IQR) reported for continuous variables, p-values from Wilcoxon rank sum test. Frequency (proportion) reported for categorical variables, with p-values from χ2 test or Fisher’s exact test. pRIFLE and Duration of AKI reported for AKI patients only.